Rare diseases
Investigational molecules
Locations
Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer
FranceStudy on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients
FranceLong-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy
FranceStudy on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
FranceStudy on Frexalimab for Patients with Relapsing Multiple Sclerosis
FranceStudy on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases
FranceStudy of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation
FranceStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on MK-0616, Ezetimibe, and Bempedoic Acid for Adults with High Cholesterol
FranceStudy of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative
FranceStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
FranceStudy on Ceralasertib and Trastuzumab Deruxtecan for Patients with Non-Small Cell Lung Cancer After Anti-PD-1/PD-L1 Therapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
